Immunotherapy News and Research

Latest Immunotherapy News and Research

Glutamine-blocking compound slows cancer growth, unleashes anti-tumor immune response

A compound developed by Johns Hopkins researchers that blocks glutamine metabolism can slow tumor growth, alter the tumor microenvironment and promote the production of durable and highly active anti-tumor T cells.

10 Nov 2019

Genetic diversity impacts efficacy of cancer immunotherapy

The constant battle against infectious pathogens has had a decisive influence on the human immune system over the course of our evolution.

8 Nov 2019

Scientists discover role for vitamin D in melanoma

A new study published in Cancer Research suggests that high levels of vitamin D may reduce the aggressive nature of melanoma cells and improve survival rates.

8 Nov 2019

New information on benefits of oral food challenges when diagnosing food allergies

Oral food challenges (OFCs) are the gold standard for allergists when diagnosing a food allergy. The person being tested is given a very small dose of the food by mouth under the supervision of a board-certified allergist to test for a severe reaction.

8 Nov 2019

Three studies present new information on penicillin allergy

At some point you may have had a reaction to penicillin and were told you were allergic. And there's a good chance it has stayed in your chart throughout your childhood and into adulthood.

8 Nov 2019

Study: Parents of pediatric patients equally satisfied with in-person appointments and telemedicine

Telemedicine visits may still seem like a futuristic idea for many. But a new study being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Houston showed most parents of pediatric patients were more or equally satisfied with the treatment their children received during telemedicine visits for allergies and asthma.

8 Nov 2019

Allergy shots effective in reducing PFAS symptoms in pediatric patients

We know that children with pollen food allergy syndrome (PFAS) also suffer from seasonal allergies.

8 Nov 2019

Online information on food allergies has negative impact on medical decisions

The social media stream on food allergies is never-ending. Your Facebook and Twitter friends seem to know what they're talking about. And why shouldn't you believe all those news articles – even if you've never heard of some of the sources?

8 Nov 2019

Study shows link between family history of cancer and childhood asthma diagnosis

It's well known there's a genetic component to cancer, and that cancer often runs in families. A new study being presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting in Houston shows an association between a family history of cancer and a childhood asthma diagnosis.

8 Nov 2019

Improved gene editing technique can successfully cut out undesirable genetic information

City of Hope researchers may have found a way to sharpen the fastest, cheapest and most accurate gene editing technique, CRISPR-Cas9, so that it can more successfully cut out undesirable genetic information.

7 Nov 2019

New model could predict response of HIV-infected individuals to cancer immunotherapy

A group of researchers at UPF and the Marchuk Institute of Numerical Mathematics in Moscow, Russia, have designed a mathematical model to predict the response of HIV-infected individuals to a type of cancer immunotherapy.

7 Nov 2019

NLCRT expands portal of resources to help Americans fight lung cancer

The National Lung Cancer Roundtable has expanded its portal of resources to help Americans fight lung cancer. The updated Resource Center includes new videos, infographics, research, and more.

6 Nov 2019

Penn researchers tag CAR T cells with imaging markers to monitor cancer therapy

With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?

5 Nov 2019

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

The Human Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.

5 Nov 2019

Researchers discover new process of antitumor response of NK cells in myeloma

NK cells mean Natural Killer cells. They are part of the innate immune system. They are known primarily for their ability to recognize and kill tumor cells, cells infected by viruses and bacteria, or dying by apoptosis. Although evidence about their antitumoral capacity, how this activity occurred remained unknown.

5 Nov 2019

Researchers develop new type of transposase protein with improved biochemical properties

The team, comprising researchers from the European Molecular Biology Laboratory, the Universitätsklinikum Würzburg and the Paul-Ehrlich-Institut, managed to design a new variant of the Sleeping Beauty transposase with dramatically improved biochemical properties.

4 Nov 2019

UK aims to lead with cutting-edge radiation therapy

The UK is all set to launch its run into the future as the undisputed leader in the field of personalized and effective radiation therapy. The proposal is undergirded by a whopping £56 million, which will be used to set up and fund advanced radiation therapy research by a new collaborative setup, Cancer Research UK RadNet, over five years. This is the largest sum ever invested by this organization into radiotherapy research.

4 Nov 2019

Facts about lung cancer and ways to reduce your risk

Lung cancer is the second most common cancer in both men and women in the United States. According to the American Cancer Society, about 13% of all new cancers are lung cancers. There will be an estimated 228,000 new cases of lung cancer this year, with more than 142,000 deaths. Moreover, the 5-year survival rate is less than 20%.

4 Nov 2019

Moffitt study discovers cellular mechanism controlling tumor cell recognition by immune cells

Immunotherapy has become a standard treatment approach for several types of cancer, including melanoma.

1 Nov 2019

Correlates of HIV risk associated with decrease in disease transmission, study confirms

Immune responses that are associated with a decreased risk of infection are called correlates of protection.

1 Nov 2019

Immunotherapy News and Research

Latest Immunotherapy News and Research

Glutamine-blocking compound slows cancer growth, unleashes anti-tumor immune response

Genetic diversity impacts efficacy of cancer immunotherapy

Scientists discover role for vitamin D in melanoma

New information on benefits of oral food challenges when diagnosing food allergies

Three studies present new information on penicillin allergy

Study: Parents of pediatric patients equally satisfied with in-person appointments and telemedicine

Allergy shots effective in reducing PFAS symptoms in pediatric patients

Online information on food allergies has negative impact on medical decisions

Study shows link between family history of cancer and childhood asthma diagnosis

Improved gene editing technique can successfully cut out undesirable genetic information

New model could predict response of HIV-infected individuals to cancer immunotherapy

NLCRT expands portal of resources to help Americans fight lung cancer

Penn researchers tag CAR T cells with imaging markers to monitor cancer therapy

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

Researchers discover new process of antitumor response of NK cells in myeloma

Researchers develop new type of transposase protein with improved biochemical properties

UK aims to lead with cutting-edge radiation therapy

Facts about lung cancer and ways to reduce your risk

Moffitt study discovers cellular mechanism controlling tumor cell recognition by immune cells

Correlates of HIV risk associated with decrease in disease transmission, study confirms

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in